Skip to content

Retrieval Study and Histological Examination Of A Hip Femoral Components With Hydroxyapatite Coatings

Retrieval Study and Histological Examination Of A Hip Femoral Components With Hydroxyapatite Coatings

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00757653
Enrollment
57
Registered
2008-09-23
Start date
2003-10-31
Completion date
2009-12-31
Last updated
2017-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Neck Fractures

Brief summary

Retrieval study and histological examination of BiMetric Femoral Components with hydroxyapatite coatings.

Detailed description

A single type of femoral component with 3 different HA coatings will be evaluated in this study. Patients with fractured neck of femur requiring hemi-arthroplasty will be recruited. Safety and performance of the device will be determined by adverse events (device related or non-related), survival and histological exam.

Interventions

DEVICEHip stem with plasma sprayed porous Ti 6Al4V alloy + plasma sprayed HA

Hip stem with plasma sprayed porous Titanium 6Al4V alloy + plasma sprayed HA

DEVICEHip stem with plasma spayed porous Titanium 6Al4V alloy + Bonemaster HA

Hip stem with plasma spayed porous Titanium 6Al4V alloy + Bonemaster HA

DEVICEHip stem with Interloc Titanium surface + Bonemaster H.A

Hip stem with Interloc Titanium surface + Bonemaster H.A

Sponsors

Biomet U.K. Ltd.
CollaboratorINDUSTRY
Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Fractured neck of femur requiring hemi-arthroplasty. Selection of subjects for this evaluation should include the following considerations:-. * A likelihood of obtaining relief of pain and improved function. * Full skeletal maturity. * Ability to follow instructions. * Good general health for age. * Willing to return for follow-up evaluations . * No bias to sex.

Exclusion criteria

• None

Design outcomes

Primary

MeasureTime frame
Adverse EventAnytime

Secondary

MeasureTime frame
Histological ExamAnytime

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026